often incidentally on abdominal imaging for another purpose; and
WHEREAS, Abdominal aortic aneurysms are usually asymptomatic,
showing no signs of its development until rupture; and
WHEREAS, Rupture of the abdominal aorta is often lethal, with
a mortality rate of 85% to 90%, and of those persons who reach
the hospital after an abdominal aortic aneurysm, only 50% to 70%
survive; and
WHEREAS, The majority of abdominal aortic aneurysms are the
result of atherosclerosis, a chronic degenerative disease of the
artery wall in which fat, cholesterol and other substances build
up in the walls of the arteries and form plaques; and
WHEREAS, A major risk factor for the development of an
abdominal aortic aneurysm is smoking, and more than 90% of
patients with such aneurysms have been smokers; and
WHEREAS, Other risk factors include being over 60 years of
age, being male, as occurrence in males is four to five times
greater than that of females, having a family history of
abdominal aortic aneurysms, genetic factors, high cholesterol,
high blood pressure, diabetes and obesity; and
WHEREAS, Most Americans afflicted with the condition are men
over 65 years of age, with the United States Preventive Services
Task Force recommending screening in men 65 to 75 years of age
with a history of smoking and selective screening in men 65 to
75 years of age without a history of smoking; and
WHEREAS, Medicare Part B covers an abdominal aortic
ultrasound screening once if an individual is considered at
risk, meaning, an individual that has a family history of
abdominal aortic aneurysms or a man between 65 to 75 years of
age that has smoked at least 100 cigarettes in his lifetime; and
WHEREAS, Treatment for abdominal aortic aneurysms includes
20200HR0690PN3208 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30